Drosophila Orthologues to Human Disease Genes: An Update on Progress

[1] Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila [J]. ONCOGENE, 2000, 19 (24) : 2803 - 2811

[2] Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics [J]. CHEMOTHERAPY, 2007, 53 (04) : 233 - 256

[3] Notch signaling in hematopoiesis and early lymphocyte development [J]. IMMUNOLOGICAL REVIEWS, 2002, 187 : 75 - 86

[4] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J]. SCIENCE, 1997, 277 (5328) : 965 - 968

[5] Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (01) : 355 - 361

[6] Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J]. SCIENCE, 2002, 295 (5556) : 865 - 868

[7] Regulation of invasive cell behavior by taiman, a Drosophila protein related to AlB1, a steroid receptor coactivator amplified in breast cancer [J]. CELL, 2000, 103 (07) : 1047 - 1058

[8] The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis [J]. MECHANISMS OF DEVELOPMENT, 2002, 111 (1-2) : 115 - 123

[9] Bickler PE, 2002, J EXP BIOL, V205, P3579

[10] Drosophila as a model for human neurodegenerative disease [J]. ANNUAL REVIEW OF GENETICS, 2005, 39 : 153 - 171

[1] Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila [J]. ONCOGENE, 2000, 19 (24) : 2803 - 2811

[2] Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics [J]. CHEMOTHERAPY, 2007, 53 (04) : 233 - 256

[3] Notch signaling in hematopoiesis and early lymphocyte development [J]. IMMUNOLOGICAL REVIEWS, 2002, 187 : 75 - 86

[4] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J]. SCIENCE, 1997, 277 (5328) : 965 - 968

[5] Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (01) : 355 - 361

[6] Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J]. SCIENCE, 2002, 295 (5556) : 865 - 868

[7] Regulation of invasive cell behavior by taiman, a Drosophila protein related to AlB1, a steroid receptor coactivator amplified in breast cancer [J]. CELL, 2000, 103 (07) : 1047 - 1058

[8] The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis [J]. MECHANISMS OF DEVELOPMENT, 2002, 111 (1-2) : 115 - 123

[9] Bickler PE, 2002, J EXP BIOL, V205, P3579

[10] Drosophila as a model for human neurodegenerative disease [J]. ANNUAL REVIEW OF GENETICS, 2005, 39 : 153 - 171